Sean Lee
Stock Analyst at HC Wainwright & Co.
(4.05)
# 507
Out of 5,129 analysts
103
Total ratings
32.67%
Success rate
21.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DWTX Dogwood Therapeutics | Reiterates: Buy | $12 | $3.02 | +297.35% | 3 | Jan 30, 2026 | |
| KZIA Kazia Therapeutics | Reiterates: Buy | $18 | $5.46 | +229.67% | 7 | Jan 28, 2026 | |
| PSTV Plus Therapeutics | Maintains: Buy | $2 → $1 | $0.26 | +280.08% | 14 | Jan 23, 2026 | |
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $11 → $27 | $19.58 | +37.90% | 4 | Jan 20, 2026 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $24 | $13.90 | +72.66% | 14 | Jan 12, 2026 | |
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.67 | +11.94% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $8.28 | +123.43% | 3 | Nov 6, 2025 | |
| NVAX Novavax | Maintains: Buy | $10 → $11 | $8.75 | +25.71% | 2 | Oct 23, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.24 | +560.88% | 2 | Sep 9, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $0.85 | +370.26% | 10 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $5 | $0.82 | +512.00% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $6.28 | +122.93% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $57.28 | -30.17% | 10 | Apr 1, 2025 |
Dogwood Therapeutics
Jan 30, 2026
Reiterates: Buy
Price Target: $12
Current: $3.02
Upside: +297.35%
Kazia Therapeutics
Jan 28, 2026
Reiterates: Buy
Price Target: $18
Current: $5.46
Upside: +229.67%
Plus Therapeutics
Jan 23, 2026
Maintains: Buy
Price Target: $2 → $1
Current: $0.26
Upside: +280.08%
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11 → $27
Current: $19.58
Upside: +37.90%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $13.90
Upside: +72.66%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.67
Upside: +11.94%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $8.28
Upside: +123.43%
Novavax
Oct 23, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $8.75
Upside: +25.71%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.24
Upside: +560.88%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $0.85
Upside: +370.26%
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.82
Upside: +512.00%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $6.28
Upside: +122.93%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $57.28
Upside: -30.17%